{
    "Trade/Device Name(s)": [
        "Omnyx Manual Read of the Digital HER2 Application"
    ],
    "Submitter Information": "Omnyx, LLC",
    "510(k) Number": "K131140",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071671",
        "K111543"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OEO"
    ],
    "Summary Letter Date": "March 12, 2014",
    "Summary Letter Received Date": "March 13, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "immunology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "HER2/neu (c-erbB-2)"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded (FFPE) breast cancer tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Omnyx IDP System",
        "Omnyx VL4 Scanner",
        "Computer monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Digital image acquisition",
        "Manual digital interpretation",
        "Immunohistochemistry (IHC)"
    ],
    "Methodologies": [
        "Image acquisition",
        "Slide scanning",
        "Manual interpretation of digital IHC slides"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Workstation",
        "Scanner",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Omnyx Manual Read of the Digital HER2 Application for manual digital interpretation of HER2 IHC slides in breast cancer using digital pathology system",
    "Indications for Use Summary": "Intended as an aid for pathologists in detection and semi-quantitative measurement of HER2/neu in digital images of FFPE breast cancer tissue immunohistochemically stained with the Dako HercepTest and viewed on a computer monitor; aids assessment of breast cancer patients for whom HERCEPTIN (Trastuzumab) treatment is considered.",
    "fda_folder": "Hematology"
}